ENTITY

CSL (CSL AT)

1
Analysis
Health CareUnited States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
07 Jun 2024 10:03

ASX Short Interest Weekly (May 31st): Wisetech Global, Pro Medicus, CSL, IDP Education, Boral

We analyzed ASX short interest report for the past week and highlight short interest changes in Wisetech Global, Pro Medicus, CSL, IDP Education,...

Logo
537 Views
Share
bullishTerumo Corp
23 May 2024 22:41

Terumo Corp (4543 JP): Q4 Result Beats Guidance; Double-Digit Profit Growth to Continue in FY25

​Terumo reported 18% revenue growth in Q4FY24, with operating profit up 45%. FY25 outlook includes revenue of ¥980B, op. profit of ¥165B, and net...

Logo
327 Views
Share
01 Apr 2024 05:00

Australia Short Interest (Q1 2024): A Recap

Total short interest in Australia is A$34.46bn and has decreased by A$1.36bn since the start of the year. We look at the stocks with the largest...

Logo
353 Views
Share
29 Mar 2024 10:19

ASX Short Interest Weekly (Mar 22nd): Rio Tinto, Webjet, Xero, CSL, Westpac, Macquarie

We analyzed ASX short interest report for the past week and highlight short interest changes in Rio Tinto, Webjet, Xero, CSL, Westpac, Macquarie,...

Logo
503 Views
Share
22 Mar 2024 10:09

ASX Short Interest Weekly (Mar 15th): CSL, Paladin Energy, Macquarie, Emerald Resource

We analyzed ASX short interest report for the past week and highlight short interest changes in CSL, Paladin Energy, Macquarie, Emerald Resource,...

Logo
371 Views
Share
x